John Menditto | Vice President-Investor Relations and Corporate Communications |
David Mazzo | President and Chief Executive Officer |
Kristen Buck | Executive Vice President of R&D and Chief Medical Officer |
James Nisco | Vice President-Finance and Treasury |
Kumaraguru Raja | Brookline Capital Markets |
Emanuela Branchetti | H.C. Wainwright |
Peter Enderlin | MAZ Partners |
Welcome to the Caladrius Biosciences Third Quarter 2021 Financial Results and Business Update Conference Call. Currently all participant lines are in a listen-only mode.
Following management's prepared remarks, there will be a question-and-answer session. [Operator Instructions] As a reminder, this call is being recorded today, Thursday, November 4, 2021. I will now turn the call over to John Menditto, Vice President of Investor Relations and Corporate Communications at Caladrius.